Atenolol Tablets — Class I drug recall D-0019-2023
Terminated recall by Golden State Medical Supply Inc., reported 2022-11-02, distributed nationwide. Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
| Recall number | D-0019-2023 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Golden State Medical Supply Inc., Camarillo, CA, United States |
| Recall initiated | 2022-09-29 |
| Classified | 2022-10-21 |
| Reported by FDA | 2022-11-02 |
| Terminated | 2025-03-20 |
| Distributed | Nationwide (US) |
| Quantity | 2,584 bottles |
| Reason classes | labeling |
| NDC | 60429-0025, 60429-0025-10, 60429-0025-90, 60429-0026, 60429-0026-10, 60429-0026-90, 60429-0027, 60429-0027-10, 60429-0027-90 |
| Lot numbers | GS046745 |
| Expiration dates | 2023-12 |
Product
Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10
Reason for recall
Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0019-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.